Home ›
Trademark Categories ›
Pharmaceuticals ›
2012 ›
IM ›
IMREVITE
Trademark search for:
IMREVITE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-09-15 — Application filed
2020-09-18 — Application filed
2020-10-22 — Application filed
2020-11-18 — Assigned to examiner
2020-11-19 — Final disposition recorded
2020-11-19 — Final disposition recorded
2020-11-19 — Final disposition recorded
2021-05-17 — Teas/email correspondence entered
2021-05-17 — Office action issued
2021-05-17 — Correspondence received in law office
2021-05-18 — Approved for pub - principal register
2021-06-02 — Notification of notice of publication e-mailed
2021-06-22 — Published for opposition
2021-06-22 — Official gazette publication confirmation e-mailed
2021-08-17 — Noa e-mailed - sou required from applicant
2022-02-08 — Sou teas extension received
2022-02-08 — Sou extension 1 filed
2022-02-08 — Sou extension 1 granted
2022-02-10 — Notice of approval of extension request e-mailed
2022-07-27 — Sou teas extension received
2022-07-27 — Sou extension 2 filed
2022-07-27 — Sou extension 2 granted
2022-07-29 — Notice of approval of extension request e-mailed
2023-02-13 — Sou teas extension received
2023-02-13 — Sou extension 3 filed
2023-02-13 — Sou extension 3 granted
2023-02-15 — Notice of approval of extension request e-mailed
2023-08-02 — Sou teas extension received
2023-08-02 — Teas change of owner address received
2023-08-02 — Teas change of correspondence received
2023-08-02 — Sou extension 4 granted
2023-08-02 — Applicant/correspondence changes (non-responsive) entered
2023-08-02 — Sou extension 4 filed
2023-08-04 — Notice of approval of extension request e-mailed
2024-01-12 — Sou teas extension received
2024-01-12 — Sou extension 5 filed
2024-01-30 — Case assigned to intent to use paralegal
2024-01-31 — Sou extension 5 granted
2024-02-01 — Notice of approval of extension request e-mailed
2024-09-23 — Application abandoned
2024-09-23 — Application abandoned
2024-09-23 — Final status recorded
Owner Information
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Correspondent
Marilyn F. Kelly BRISTOL-MYERS SQUIBB COMPANY
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
